| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 2001- | Ash, | Withania somnifera: from prevention to treatment of cancer |
| - | Review, | Var, | NA |
| 8806- | Ash, | Systematic review and network meta-analysis of the effects of plant active substance on quality of life in breast cancer patients |
| - | Review, | BC, | NA |
| 2612- | Ba, | MF, | The effect of a static magnetic field and baicalin or baicalein interactions on amelanotic melanoma cell cultures (C32) |
| - | in-vitro, | Melanoma, | NA |
| 2686- | BBR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| - | Review, | Nor, | NA |
| 1650- | CA, | Adjuvant Properties of Caffeic Acid in Cancer Treatment |
| - | Review, | Var, | NA |
| 1518- | CAP, | Capsaicin-mediated tNOX (ENOX2) up-regulation enhances cell proliferation and migration in vitro and in vivo |
| - | in-vitro, | CRC, | HCT116 |
| 9142- | CC, | immuno, | Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC) |
| - | Trial, | RCC, | NA |
| 9134- | CC, | Camu camu plus nivolumab/ipilimumab (N/I) as first-line therapy for metastatic renal cell carcinoma (mRCC): A randomized phase I trial |
| - | Trial, | RCC, | NA |
| 1586- | Citrate, | Extracellular Citrate Is a Trojan Horse for Cancer Cells |
| - | in-vitro, | Liver, | HepG2 |
| 1578- | Citrate, | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
| - | Review, | Var, | NA |
| 4769- | CoQ10, | CoQ10 Is Key for Cellular Energy and Cancer Support |
| - | Review, | Var, | NA |
| 5808- | CPT, | Repair of Topoisomerase I-Mediated DNA Damage |
| - | Review, | Var, | NA |
| 1616- | CUR, | EA, | Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid |
| - | in-vitro, | Nor, | NA |
| 8830- | DIM, | Tam, | A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen |
| - | Trial, | BC, | NA |
| 8832- | DIM, | Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy |
| - | Trial, | Pca, | NA |
| 6270- | DL, | d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1299 |
| 6366- | DRE, | A comprehensive review of the benefits of Taraxacum officinale on human health |
| - | Review, | Var, | NA |
| 6604- | Ech, | Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion |
| - | Human, | Nor, | NA |
| 6618- | Ech, | Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach |
| - | Analysis, | BC, | NA |
| 1514- | EGCG, | Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | MCF10 |
| 2144- | Ex, | Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies |
| - | Analysis, | BC, | NA |
| 2497- | FBZ, | In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells |
| - | in-vitro, | GBM, | NA |
| 8598- | FSO, | Tras, | Flaxseed oil-trastuzumab interaction in breast cancer |
| - | in-vivo, | BC, | NA |
| 1954- | GamB, | Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase |
| - | in-vitro, | HCC, | SMMC-7721 cell |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 1644- | HCAs, | PBG, | Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis |
| - | in-vitro, | Pca, | LNCaP |
| 9180- | ITCs, | SFN, | Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates Review |
| - | Review, | Var, | NA |
| 8064- | KAE, | Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | SNU-213 |
| 9006- | L-THE, | Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling |
| - | vitro+vivo, | Cerv, | HeLa |
| 8270- | LE, | Rad, | Comparative Study of the Effect of Licorice Muco-adhesive Film on Radiotherapy Induced Oral Mucositis, A Randomized Controlled Clinical Trial |
| - | Trial, | HNSCC, | NA |
| 8125- | LF, | Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) |
| - | Trial, | NSCLC, | NA |
| - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | PC, | Bxpc-3 |
| 8732- | M-Blu, | Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial |
| - | Trial, | Var, | NA |
| 8572- | Matr, | Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 8631- | MBZ, | BEV, | Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer |
| - | Trial, | CRC, | NA |
| 8479- | MFrot, | doxoR, | Dual-targeting by rotating magnetic field-driven superparamagnetic bionic nanorobots for enhanced triple-negative breast cancer therapy |
| - | vitro+vivo, | BC, | 4T1 |
| 7388- | MFrot, | Magnetoporation and magnetolysis of cancer cells via carbon nanotubes induced by rotating magnetic fields |
| - | in-vitro, | BC, | MCF7 |
| 9074- | MGF, | Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway |
| - | in-vitro, | GC, | SGC-7901 | - | in-vitro, | GC, | BGC-823 |
| 8659- | MLT, | Cisplatin, | Melatonin Sensitizes OVCAR-3 Cells to Cisplatin through Suppression of PI3K/Akt Pathway |
| - | in-vitro, | Ovarian, | OVCAR-3 |
| 8692- | MLT, | Melatonin as a Radio-Sensitizer in Cancer |
| - | Review, | Var, | NA |
| 8691- | MLT, | Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial |
| - | Trial, | Oral, | NA |
| 8918- | MP, | Cisplatin, | Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling |
| - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-231 |
| 8805- | MT/VAE, | Chemo, | Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL) |
| - | Trial, | PC, | NA |
| 8936- | MushCha, | Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis |
| - | vitro+vivo, | Lung, | LLC1 |
| 8938- | MushCha, | Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | Calu-6 |
| 9057- | PatchO, | Essential Oil Compound, Patchouli Alcohol, Represses Tumor Formation in Vivo and Causes G1 Arrest by Downregulating β-catenin Transcriptional Activity in Colon Cancer Cells (FS13-02-19) |
| - | vitro+vivo, | CRC, | HT-29 | - | vitro+vivo, | Colon, | Caco-2 |
| 1647- | PBG, | CA, | Antioxidant Properties and Phenolic Composition of Greek Propolis Extracts |
| - | Analysis, | Nor, | NA |
| 1660- | PBG, | Emerging Adjuvant Therapy for Cancer: Propolis and its Constituents |
| - | Review, | Var, | NA |
| 1666- | PBG, | Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer |
| - | Review, | Var, | NA |
| 1663- | PBG, | Propolis and Their Active Constituents for Chronic Diseases |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1114 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid